Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Miriam Álvarez Payero"'
Autor:
Noemi Martínez-López-de-Castro, Miriam Álvarez-Payero, Marisol Samartín-Ucha, Alicia Martín-Vila, Guadalupe Piñeiro-Corrales, María Rodríguez-Rodríguez, Francisco José Maceiras-Pan, Rafael Benito Melero-González, Jose María Pego-Reigosa
Publikováno v:
European Journal of Rheumatology, Vol 7, Iss 2, Pp 53-59 (2020)
Externí odkaz:
https://doaj.org/article/c34738cde0844ef39848a6ca00221174
Autor:
Alejandro Santiago Pérez, Santos Esteban Casado, Miriam Álvarez Payero, Ángel Escolano Escolano Pueyo, Ángel Guillermo Arévalo Bernabé, Núria Padullés Zamora, Pilar Diaz Ruiz, Ana María López González
Publikováno v:
Farmacia Hospitalaria.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::faf4f8a457b70ee7c69a521214d9a732
https://doi.org/10.1016/j.farma.2023.03.009
https://doi.org/10.1016/j.farma.2023.03.009
Autor:
Noemi Mrtinez-Lopez de Castro, Rafael Benito Melero-González, Miriam Álvarez-Payero, José M. Pego-Reigosa, Guadalupe Piñeiro-Corrales, Cristina Martinez-Reglero, Francisco José Maceiras-Pan, Marisol Samartín-Ucha, Alicia Martín-Vila, Maria Rodriguez-Rodriguez
Publikováno v:
Eur J Hosp Pharm
OBJECTIVES: Medication persistence, defined as the duration of time from its initiation to its discontinuation, is a surrogate for treatment effectiveness. The aim of the study was to evaluate persistence and causes of biological therapy (BT) suspens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ba462e7569dfdf1f73701491a1aac40
https://doi.org/10.1136/ejhpharm-2019-002133
https://doi.org/10.1136/ejhpharm-2019-002133
Autor:
Marisol Samartín-Ucha, Cristina Martínez-Reglero, Ana María Regueira-Arcay, Karina Lorenzo-Lorenzo, Inés Castro-Núñez, Adolfo Paradela-Carreiro, Noemi Martínez-López-de-Castro, Guadalupe Piñeiro-Corrales, Elena Yaiza Romero-Ventosa, Cristina Casanova-Martínez, David Robles-Torres, Antonio Pérez-Landeiro, Aida López-López, Sonia González-Costas, Belén Leboreiro-Enríquez, Luis Otero-Millán, María Teresa Inaraja-Bobo, Nerea García-Beloso, Miriam Álvarez-Payero, Cristina Vázquez-López
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics
WHAT IS KNOWN AND OBJECTIVE: Initial treatment recommendations of COVID-19 were based on the use of antimicrobial drugs and immunomodulators. Although information on drug interactions was available for other pathologies, there was little evidence in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27f11f7c2309d3168fcb1d1a03d68d1b
https://pubmed.ncbi.nlm.nih.gov/33368439
https://pubmed.ncbi.nlm.nih.gov/33368439
Autor:
Noemí, Martínez-López de Castro, Miriam, Álvarez-Payero, Marisol, Samartín-Ucha, Alicia, Martín-Vila, Guadalupe, Piñeiro-Corrales, José María, Pego Reigosa, María, Rodríguez-Rodríguez, Rafael Benito, Melero-González, Francisco José, Maceiras-Pan
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 43(4)
The aims of the study were to quantify adherence, determine the factors that can predict adherence and identify the consequences of poorer adherence in patients with chronic inflammatory arthropathies treated with biological therapies in daily clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6ea5bf40468b896c1c100b790b2eddec
https://pubmed.ncbi.nlm.nih.gov/31276442
https://pubmed.ncbi.nlm.nih.gov/31276442
Autor:
Miriam Álvarez-Payero, N. Martinez-Lopez De Castro, Alicia Martín-Vila, Marisol Samartín-Ucha, Jose M Pego-Reigosa, Guadalupe Piñeiro-Corrales
Publikováno v:
Infection-related rheumatic diseases.
Background The introduction of biological therapies (BT) for the treatment of chronic inflammatory arthropathies (CIA) has improved the prognosis of these diseases and the quality of life of patients. However, the safety of these drugs in the long te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2192d35c6ce202c6fa3681a9c71782ce
https://doi.org/10.1136/annrheumdis-2018-eular.5626
https://doi.org/10.1136/annrheumdis-2018-eular.5626
Autor:
Marisol Samartín Ucha, Miriam Álvarez-Payero, Noemí Martínez-López de Castro, Guadalupe Piñeiro-Corrales, Alicia Martín-Vila, José M. Pego-Reigosa
Publikováno v:
Eur J Hosp Pharm
Objective To analyse the volume and content of tweets in relation to biological treatments for chronic inflammatory arthropathies. Methods A Twitter analysis was carried out during one month using the following keywords: ’rheumatoid arthritis9, ’
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38be360cbc4256180131379538a987fa
https://europepmc.org/articles/PMC6684072/
https://europepmc.org/articles/PMC6684072/
Autor:
Alicia Martín-Vila, I Gonzalez-Suarez, Noemi Martínez-López-de-Castro, Guadalupe Piñeiro-Corrales, H Fernandez-Vega, Miriam Álvarez-Payero
Publikováno v:
Clinical pharmacy.
Background New frontline oral therapies for relapsing remitting multiple sclerosis (RRMS) are available. The change to the oral route of administration could increase adherence. 1 Purpose The aim was to assess patient adherence to new oral disease mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6840c78bf7489ea074a522ef0d5c4237
https://doi.org/10.1136/ejhpharm-2017-000640.59
https://doi.org/10.1136/ejhpharm-2017-000640.59
Autor:
Luciana Midaglia, Candelas Valeiras-Muñoz, Guadalupe Piñeiro-Corrales, Delicias Muñoz-García, Susana Lion-Vázquez, Miriam Álvarez-Payero
Publikováno v:
The International journal of neuroscience. 127(10)
Approximately 85% of patients with multiple sclerosis experience reduced mobility, which negatively affects quality of life. Fampridine is the first symptomatic treatment aimed at improving gait. We analyzed effectiveness and tolerance in clinical pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ac6f66214b995dc0e394cd55106b892
https://pubmed.ncbi.nlm.nih.gov/28054826
https://pubmed.ncbi.nlm.nih.gov/28054826
Autor:
Marisol Samartín-Ucha, Miguel Fariña-Conde, Noemi Martínez-López-de-Castro, Guadalupe Piñeiro-Corrales, Cristina Casanova-Martínez, Alicia Martín-Vila, Mónica Gayoso-Rey, Miriam Álvarez-Payero, Débora Feijoo-Meléndez, Patricia Iglesias-Neiro
Publikováno v:
European journal of hospital pharmacy : science and practice. 25(4)
Objective To analyse the factors leading to greater satisfaction among patients attending the outpatient hospital pharmacy (OPh). Methods A cross-sectional study was conducted of patients attending the OPh of a 1250-bed university hospital. A self-ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9144f14800d5f0d0ad85e03e7dc98fa3
https://pubmed.ncbi.nlm.nih.gov/31157016
https://pubmed.ncbi.nlm.nih.gov/31157016